Clinical Study of Ixabepilone Administered as a 24 Hour Infusion in Patients With Solid Malignancies.

PHASE1CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

September 30, 2005

Primary Completion Date

July 31, 2008

Study Completion Date

July 31, 2008

Conditions

Solid Malignancies

Interventions

DRUG

Ixabepilone

Intravenous (IV) Infusion; 10, 20, 30, 35, 40 \& 45 mg/m2, once every 21 days (1 cycle), up to 9 cycles

Trial Locations (3)

University Of Maryland, Baltimore

Cleveland Clinic Foundation, Cleveland

The Cancer Institute Of New Jersey, New Brunswick